Mark | Date Date | Title Title | |||
---|---|---|---|---|---|
No. 11 | 05 Mar 2004 |
The Slovak Health Insurance System and The Potential Role for Private Health Insurance
This paper analyses the Slovak health insurance system and the policy challenges it faces. It describes the structure of health coverage and health sector reforms being implemented by the Slovak government. It provides a preliminary assessment of the... |
|||
No. 10 | 12 Feb 2004 |
Private Health Insurance in Ireland
This paper analyses the Irish private health insurance (PHI) market. It describes how PHI interacts with the public system, and assesses its contribution to equity, efficiency and responsiveness of the health system. The analysis identifies some of... |
|||
No. 9 | 05 Dec 2003 |
Health-Care Systems
This study presents a broad overview of health-system reforms in OECD countries over the past several decades. Reforms are assessed according to their impact on the following policy goals: ensuring access to needed health-care services; improving the... |
|||
No. 8 | 30 Oct 2003 |
Private Health Insurance in Australia
Despite universal public insurance coverage, private health insurance (PHI) covers almost half of the Australian population – a high coverage rate in comparison with most other OECD countries. Reflecting the belief that a well-functioning health care... |
|||
No. 7 | 07 Oct 2003 |
Explaining Waiting Times Variations for Elective Surgery Across OECD Countries
Waiting times for elective surgery are a significant health policy concern in approximately half of all OECD countries. The main objectives of the OECD Waiting Times project were to: i) review policy initiatives to reduce waiting times in 12 OECD... |
|||
No. 6 | 07 Jul 2003 |
Tackling Excessive Waiting Times for Elective Surgery
Waiting times for elective (non-urgent) surgery are a main health policy concern in approximately half of OECD countries. Mean waiting times for elective surgical procedures are above three months in several countries and maximum waiting times can... |
|||
No. 5 | 06 Jun 2003 |
Stroke Care in OECD Countries
The Ageing-Related Diseases study compares health care systems by examining treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating... |
|||
No. 4 | 16 May 2003 |
Survey of Pharmacoeconomic Assessment Activity in Eleven Countries
Policy-makers responsible for publicly-funded drug programmes face continual pressures between the demand to accommodate a steady stream of new and more effective drugs and the ongoing requirement to control costs.In the face of these pressures, a... |
|||
No. 3 | 22 Apr 2003 |
OECD Study of Cross-National Differences in the Treatment, Costs and Outcomes of Ischaemic Heart Disease
The Ageing-Related Diseases study compares treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating specific diseases. Therefore, the ARD’s... |
|||
No. 2 | 22 Apr 2003 |
Investment in Population Health in Five OECD Countries
There is growing interest in the potential for preventive interventions to improve average health status in OECD countries and to tackle remaining health inequalities. The interest is in a wide range of interventions spanning not only health services... |
|||
No. 1 | 20 Feb 2003 |
Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke
This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among... |
OECD Health Working Papers
English, French
- ISSN: 18152015 (online)
- https://doi.org/10.1787/18152015
161 - 171 of 171 results
The Slovak Health Insurance System and The Potential Role for Private Health Insurance
Francesca Colombo and Nicole Tapay
05 Mar 2004
This paper analyses the Slovak health insurance system and the policy challenges it faces. It describes the structure of health coverage and health sector reforms being implemented by the Slovak government. It provides a preliminary assessment of the...
Private Health Insurance in Ireland
Francesca Colombo and Nicole Tapay
12 Feb 2004
This paper analyses the Irish private health insurance (PHI) market. It describes how PHI interacts with the public system, and assesses its contribution to equity, efficiency and responsiveness of the health system. The analysis identifies some of...
Health-Care Systems
Elizabeth Docteur and Howard Oxley
05 Dec 2003
This study presents a broad overview of health-system reforms in OECD countries over the past several decades. Reforms are assessed according to their impact on the following policy goals: ensuring access to needed health-care services; improving the...
Private Health Insurance in Australia
Francesca Colombo and Nicole Tapay
30 Oct 2003
Despite universal public insurance coverage, private health insurance (PHI) covers almost half of the Australian population – a high coverage rate in comparison with most other OECD countries. Reflecting the belief that a well-functioning health care...
Explaining Waiting Times Variations for Elective Surgery Across OECD Countries
Luigi Siciliani and Jeremy Hurst
07 Oct 2003
Waiting times for elective surgery are a significant health policy concern in approximately half of all OECD countries. The main objectives of the OECD Waiting Times project were to: i) review policy initiatives to reduce waiting times in 12 OECD...
Tackling Excessive Waiting Times for Elective Surgery
Jeremy Hurst and Luigi Siciliani
07 Jul 2003
Waiting times for elective (non-urgent) surgery are a main health policy concern in approximately half of OECD countries. Mean waiting times for elective surgical procedures are above three months in several countries and maximum waiting times can...
Stroke Care in OECD Countries
Lynelle Moon, Pierre Moïse and Stephane Jacobzone
06 Jun 2003
The Ageing-Related Diseases study compares health care systems by examining treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating...
Survey of Pharmacoeconomic Assessment Activity in Eleven Countries
Michael Dickson, Jeremy Hurst and Stephane Jacobzone
16 May 2003
Policy-makers responsible for publicly-funded drug programmes face continual pressures between the demand to accommodate a steady stream of new and more effective drugs and the ongoing requirement to control costs.In the face of these pressures, a...
OECD Study of Cross-National Differences in the Treatment, Costs and Outcomes of Ischaemic Heart Disease
Pierre Moïse and Stephane Jacobzone
22 Apr 2003
The Ageing-Related Diseases study compares treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating specific diseases. Therefore, the ARD’s...
Investment in Population Health in Five OECD Countries
Jan Bennett
22 Apr 2003
There is growing interest in the potential for preventive interventions to improve average health status in OECD countries and to tackle remaining health inequalities. The interest is in a wide range of interventions spanning not only health services...
Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke
Michael Dickson and Stephane Jacobzone
20 Feb 2003
This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among...